NewAmsterdam Pharma (NAMS) Earnings Date & Reports
A.I. Advisor
published Earnings
NAMS is expected to report earnings to rise 19.83% to -49 cents per share on November 11
Q3'24
Est.
$-0.49
Q2'24
Beat
by $0.17
Q1'24
Missed
by $0.44
Q4'23
Beat
by $0.04
Q3'23
Beat
by $0.31
The last earnings report on August 07 showed earnings per share of -40 cents, beating the estimate of -57 cents. With 129.20K shares outstanding, the current market capitalization sits at 1.46B.